Merck's Gardasil franchise generated $1 billion in the third quarter, prompting an analyst to wonder just how much the shot might be able to generate in the long run.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,